$ Value
$112K
Shares
13,861
Price
$8
Filed
Jun 3
Insider
Name
Waheed Nadia
Title
Chief Medical Officer
CIK
0002023884
Roles
Transaction Details
Transaction Date
2025-06-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
206,805
Footnotes
Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on June 1, 2025. The sales do not represent a discretionary trade by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.94 to $8.16, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Filing Info
Waheed Nadia's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | OCUL | ▼ | $27K |
| 2026-02-12 | OCUL | ▼ | $71K |
| 2026-01-02 | OCUL | A | $0 |
| 2026-01-02 | OCUL | A | $0 |
| 2025-08-12 | OCUL | A | $0 |
| 2025-08-12 | OCUL | A | $0 |
| 2025-06-02 | OCUL | ▼ | $112K |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LINDSTROM RICHARD L MD | $461K | — | 2026-02-20 |
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |